CLOV P/E Ratio
P/E Ratio as of Jun 12, 2025: -57.45
Average-63.15
Median-61.86
Minimum-72.35
Maximum-57.45
-57.45
Past Month+10.59 (15.56%)
The P/E ratio for CLOV is -57.45 as of Jun 12, 2025. This represents a increase of 100.73% compared to its 12-month average P/E ratio of -28.62. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Clover Health Investments P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clover Health Investments’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clover Health Investments to industry peers.
Clover Health Investments P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clover Health Investments’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clover Health Investments to industry peers.
CLOV P/E Ratio Insights
See Clover Health Investments’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CLOV
Order type
Buy in
Order amount
Est. shares
0 shares
CLOV P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $3.17 | -62.16 |
| May 1, 2025 | $3.32 | -37.81 |
| Apr 1, 2025 | $3.59 | -40.89 |
| Mar 3, 2025 | $3.64 | -41.46 |
| Feb 3, 2025 | $4.31 | -49.09 |
| Jan 2, 2025 | $3.13 | -35.65 |
CLOV End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -57.45 | +60.12% |
| 2024 | -35.88 | +1,685.07% |
| 2023 | -2.01 | +101.00% |
| 2022 | -1.00 | -62.96% |
| 2021 | -2.70 | -98.95% |
| 2020 | -257.21 | — |
FAQs About Clover Health Investments (CLOV) P/E ratio
The latest P/E ratio of CLOV is -57.45, as of Jun 12, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Clover Health Investments’s last 12-month average P/E ratio is -28.62, compared to its current P/E ratio of -57.45. This reflects a increase of 100.73%.
Clover Health Investments’s current P/E ratio of -57.45 is higher than its last 12-month average P/E of -28.62. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Clover Health Investments’s average P/E ratio over the last 3 years is -10.9. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Clover Health Investments’s average P/E ratio over the last 5 years is -53.18. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.